Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
15 May 2012 | North America | Market Research
Mölnlycke Health Care—Company Profile
This market insight provides an overview of Mölnlycke Health Care. The Mölnlycke company was established in 1849 by G.F. Henning as primarily a textile manufacturer. In 1997, Mölnlycke Health Care came in to existence when Nordic Capital acquired the medical devices segment of SCA. The company is currently owned by Investor AB and has seen stea...
$1,500.00 -
04 Mar 2013 | North America | Market Research
Analysis of the U.S. Magnetic Resonance Imaging (MRI) Systems Market
An Assessment and Outlook through 2016
This research service evaluates the U.S. MRI systems market during the 2008 to 2016 time period. It provides analyses of the less than or equal to 1.5 Tesla and 3.0 Tesla market segments at the total market and individual segment levels. Content in this research service includes market background, technology trends, market drivers and restraints, a...
$4,950.00 -
03 Jun 2013 | North America | Market Research
US and European Digital Pathology Systems Market
Growth in Digital Pathology is Slow but Promising and is Poised to Reshape Anatomic Pathology
The research service provides an overview of the US and the European digital pathology systems market and provides a 7-year forecast from 2013 to 2019. For the purpose of this study, digital pathology is defined as those systems, applications, and services that provide a digital environment for the management and interpretation of pathology studies...
$4,950.00 -
26 Sep 2013 | North America | Market Research
US Medical Radiopharmaceuticals Market
New Growth Opportunities Emerge in a Strenuous Market
This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as wit...
$4,950.00 -
27 Feb 2014 | North America | Market Research
US and European Sleep Disorder Diagnostic Devices Market
Cost-effective Solutions in Home Sleep Tests Stir Market Growth
This research service studies the qualitative and the quantitative aspects of the sleep disorder diagnostic devices market in Europe and the United States. The study includes clinical polysomnogram (PSG) systems and ambulatory PSG systems. The countries in this research include: Germany, France, Italy, Spain, the United Kingdom, the United States, ...
$4,950.00 -
06 May 2014 | North America | Market Research
US Nuclear Medicine and PET Imaging Systems Market
Molecular Imaging Falls Short of Realizing Full Growth Potential
This research service pertains to the US market for nuclear medicine and positron emission tomography (PET) imaging systems. Providing thorough market sizing and forecast of market revenue, unit shipments, procedure volumes, average pricing, and installed base, the study analyzes market trends, drivers and restraints, along with the reimbursement a...
$4,950.00 -
31 Mar 2015 | North America | Market Research
Advances in rehabilitation devices -- Technical Insights
Technological Solutions in Rehabilitation Devices
This Technical Insights Research Service (RS) highlights technological advances that are enabling rehabilitation devices. Innovations in core technologies, incremental product enhancements, and convergence of different technologies are assessed. This global industry study, analyzes the market accelerators and challenges, recent IP activity in this ...
$3,950.00 -
16 Apr 2015 | North America | Market Research
Big Data Opportunities in the US Medical Imaging Market
Assessing Market Opportunities for Big Data Management and Big Data Analytics in Medical Imaging
Medical imaging data volumes will soon be approaching the petabyte range forcing providers to explore Big Data tools to help capture, manage, view, and analyze data. Leading medical imaging and non-healthcare IT vendors are investing in solutions as well as business strategies to support the healthcare industry as it progresses on the Big Data jour...
$3,950.00 -
05 Nov 2015 | North America | Market Research
Analysis of the US Breast Imaging Systems Market
A Guide to One of Medical Imaging’s Key Multi-modality Hubs
This research service presents an analysis of the breast imaging systems market in the United States. It provides an in-depth analysis of the current trends, market size, revenue forecast, drivers and restraints, market penetration, and market attractiveness. Segments that are covered include X-ray mammography (with analog, digital radiography, co...
$4,950.00 -
08 Nov 2016 | North America | Market Research
The US Molecular Diagnostics Market, Forecast to 2021
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
$4,950.00
